DOI: 10.1055/s-00034925

Hämostaseologie

LinksClose Window

References


Janssen Submits New Drug Application to U.S. FDA for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients | Johnson & Johnson [Internet].
Content Lab US. [cited November 16, 2021]. Accessed January 30, 2022 at:
https://www.jnj.com/janssen-submits-new-drug-application-to-u-s-fda-for-xarelto-rivaroxaban-to-help-prevent-and-treat-blood-clots-in-pediatric-patients

Download Bibliographical Data

Search in:

We do not assume any responsibility for the contents of the web pages of other providers.